Domestic ECMO Production Needed to Lower Costs in India
Medical experts are calling for the domestic manufacturing of Extra-Corporeal Membrane Oxygenation (ECMO) machines under the “Make in India” initiative to reduce prohibitive treatment expenses and address a critical shortage of trained specialists nationwide.
Key Highlights
- India’s ECMO usage remains 50 times lower than international figures due to exorbitant costs and an acute deficit of trained clinical experts.
- Domestic production via the “Make in India” initiative is projected to make life-saving advanced critical care affordable for all socioeconomic segments.
- Medical leaders emphasize that expanding public awareness of ECMO technology is vital for timely critical care interventions.
Guntur Medical, June 21: Advanced Extra-Corporeal Membrane Oxygenation technology serves as a vital life-support system capable of saving patients experiencing acute heart and lung failure, according to Dr. Pranay Oja, Course Director of the ECMO Society of India.
The medical expert delivered these remarks as the chief guest during the Ecmocon medical conference on Sunday. The event was organized by the Guntur branch of the Indian Society of Critical Care Medicine alongside the ECMO Society of India.
Dr. Oja revealed that clinical utilization of ECMO systems within India lags 50 times behind international benchmarks. He attributed this massive disparity directly to the expensive nature of the therapy and a severe lack of specialized training among healthcare professionals.
Manufacturing these medical systems domestically under the Make in India initiative could democratize access to the treatment in the future. Dr. Venkat Goyal, another director, further stressed the urgent necessity of building widespread patient awareness regarding the capabilities of ECMO systems.
Future Outlook for Indigenous Medical Devices
The localized production of high-end medical equipment represents the next frontier for the Indian healthcare ecosystem. Transitioning from import dependency to domestic fabrication is expected to drastically lower capital costs for hospitals, which will subsequently reduce patient billing for advanced life-support procedures. Industry analysts project that establishing domestic production lines will also incentivize institutional training programs, creating a robust pipeline of certified perfusionists and critical care specialists across regional medical centers by 2027.
FAQs
What is an ECMO machine and how does it function?
An Extra-Corporeal Membrane Oxygenation machine is an advanced life-support system that takes over the function of the heart and lungs. It pumps blood outside the body, removes carbon dioxide, adds oxygen, and returns the blood to the patient, allowing the organs to rest and recover.
Why is ECMO utilization low in India compared to other countries?
ECMO utilization in India is 50 times lower than foreign nations primarily because the equipment and operational procedures are highly expensive. Additionally, there is a significant shortage of properly trained medical experts capable of managing the technology.
How can the Make in India initiative impact critical healthcare?
Manufacturing ECMO machines domestically under the Make in India initiative will lower production expenses. This cost reduction will make life-saving advanced treatments accessible and affordable for patients across all socioeconomic backgrounds.
